Portola Capital Partners is a healthcare investment and advisory firm that focuses on innovation, growth and cross-border deals in North America, Asia, Europe and emerging markets. The firm also focuses on investing in emerging public and private biotechnology and device companies.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Aptinyx | 15-Sep-2015 | Seed Round | Drug Discovery | Generating Revenue/Not Profitable | ||
000000 | 02-Dec-2014 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Aptinyx | 21-Jun-2018 | IPO | 00000 |
000000 | 28-Aug-2015 | 000000000000000000 | 00.000 |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Sasha Blaug Ph.D | Senior Investment Analyst & Vice President | New York, NY |